The Alzheimer’s drugs on the market today help compensate for the problems caused by Alzheimer’s. However, they do not stop the disease or change its
VIDEO The A4 Study uses the drug solanezumab in one of the most ambitious attempts yet to thwart Alzheimer’s. The major clinical trial got underway
Research has shown that the Parkinson’s drug, rasagiline, could be a viable therapeutic option for people with Alzheimer’s disease. Learn about the new effort to
VIDEO + ARTICLE CERE-110 is a big step forward for Alzheimer’s clinical trials. It induces brain cells to make their own nerve-growth-factor, so they can
VIDEO & ARTICLE: See how doctors implant a deep-brain-stimulation device in “The Advance Study”. Learn how its electrodes stimulate a part of the brain called
VIDEO+ARTICLE Cognoptix announced strong results in a clinical trial of its SAPPHIRE II eye test. It successfully identified Alzheimer’s via the human eye’s beta-amyloid signature.
VIDEO + ARTICLE IVIG is an FDA-Approved medication. It has been prescribed off-label for Alzheimer’s. Despite recent failures in clinical trials, pharmaceutical companies and academic
RADIO & ARTICLE Hear Ronald Peterson, head of the U.S. government’s National Alzheimer’s Project Act, explore the results of 4 new studies on bexarotene (Brand
Targacept is taking a confident approach in its latest clinical trial. Rather than pitting their new Alzheimer’s drug against a placebo, they are putting it
VIDEO & ARTICLE Bexarotene is an FDA-approved anti-cancer drug available under the brand name Targretin®. It clears Alzheimer’s biomarkers in mice like a charm. See
The good news is that a new initiative called ADDI is pooling research data to accelerate curing Alzheimer’s. Watch Bill Gates on the Alzheimer’s Disease Data Initiative.
CUTTING-EDGE VIDEO + ARTICLE: See Dr. Anthony Fitzpatrick use world-class cryo-electron microscopes to reveal molecular secrets leading to a cure for Alzheimer’s.
UPLIFTING VIDEO: Peter Berry & his Alzheimer’s are cycling 350 miles to show it’s still possible to live well with dementia.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.
